Investigative Site Number: 3760002
Ramat Gan 52621
1 studies enrolling now · 1 studies all time
What they study most
Type 1 Diabetes
Studies at this site
- Long-Term Outcomes of Teplizumab in Routine Clinical Care — Recruiting now
Ramat Gan 52621
1 studies enrolling now · 1 studies all time
Type 1 Diabetes